The Botanical Research Resource Core will serve as a resource to for all four projects in this Botanical Research Center. It will centralize the acquisition and authentication process of the botanical test materials in the early phase. Then it will be responsible for fractionating and characterizing the active components from botanicals identified as active in projects by Livingston and Cheung. In the final phase, this core will oversee the formulation and preparation of two optimized products for clinical trials. The core will be led by Dr Ping Chung Leung of the Institute of Chinese Medicine (ICM) of The Chinese University of Hong Kong (CUHK). It has pooled together a panel of experts in botanical medicine, herb formulation, biochemistry, plant genetics and clinical trials at CUHK to offer professional and logistical support to the projects. A systematic approach has been developed by the ICM to study botanical products through chemical characterization, pharmacological screening, pharmacokinetic studies, safety studies, and dosage formulation. This unified approach will facilitate quality control and streamline the overall effort making it more cost effective.
Specific Aims are: 1) To centralize procedures for the acquisition and authentication of botanical test materials for all research projects. 2) To extract, fractionate and characterize the active components of botanicals selected in Projects by Livingston and Cheung. 3) To oversee the formulation, preparation and quality assurance analyses of botanical study agents for clinical trials in Project by Cassileth.

Agency
National Institute of Health (NIH)
Institute
National Center for Complementary & Alternative Medicine (NCCAM)
Type
Specialized Center (P50)
Project #
5P50AT002779-04
Application #
7641080
Study Section
Special Emphasis Panel (ZAT1)
Project Start
Project End
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
4
Fiscal Year
2008
Total Cost
$56,800
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Wesa, Kathleen M; Cunningham-Rundles, Susanna; Klimek, Virginia M et al. (2015) Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study. Cancer Immunol Immunother 64:237-47
Fonseca, Fabiana N; Papanicolaou, Genovefa; Lin, Hong et al. (2014) Echinacea purpurea (L.) Moench modulates human T-cell cytokine response. Int Immunopharmacol 19:94-102
Yue, Grace G L; Cheng, Sau-Wan; Yu, Hua et al. (2012) The role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal Caco-2 cells. J Med Food 15:242-52
Xiao, Wei-Lie; Motley, Timothy J; Unachukwu, Uchenna J et al. (2011) Chemical and genetic assessment of variability in commercial Radix Astragali (Astragalus spp.) by ion trap LC-MS and nuclear ribosomal DNA barcoding sequence analyses. J Agric Food Chem 59:1548-56
Yuan, Jianda; Ginsberg, Brian; Page, David et al. (2011) CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases. Cancer Immunol Immunother 60:1137-46
Hong, Feng; Xiao, Weilie; Ragupathi, Govind et al. (2011) The known immunologically active components of Astragalus account for only a small proportion of the immunological adjuvant activity when combined with conjugate vaccines. Planta Med 77:817-24
Ku, Geoffrey Y; Yuan, Jianda; Page, David B et al. (2010) Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival. Cancer 116:1767-75
Yue, Grace G L; Chan, Ben C L; Hon, Po-Ming et al. (2010) Immunostimulatory activities of polysaccharide extract isolated from Curcuma longa. Int J Biol Macromol 47:342-7
Fusco, Dahlene; Liu, Xinyan; Savage, Caroline et al. (2010) Echinacea purpurea aerial extract alters course of influenza infection in mice. Vaccine 28:3956-62
Lin, Hong; de Stanchina, Elisa; Zhou, Xi Kathy et al. (2010) Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicity. Cancer Immunol Immunother 59:885-97

Showing the most recent 10 out of 29 publications